Cargando…

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors

This review highlights the potential role of cyclooxygenase-2 enzyme (COX-2) in the pathogenesis of Alzheimer's disease (AD) and the potential therapeutic use of non-steroidal anti-inflammatory drugs (NSAIDs) in the management of AD. In addition to COX-2 enzymes role in inflammation, the format...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moussa, Nathalie, Dayoub, Ninar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448476/ https://www.ncbi.nlm.nih.gov/pubmed/37638222 http://dx.doi.org/10.1016/j.jsps.2023.101729

Ejemplares similares

Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox-2
por: Voutsadakis, Ioannis A
Publicado: (2007)

COX-2 Inhibitors and Gastric Cancer
por: Wang, Zhen, et al.
Publicado: (2014)

Adverse Effects of COX-2 Inhibitors
por: Sharma, Jagdish N., et al.
Publicado: (2005)

COX-2 as a potential biomarker and therapeutic target in melanoma
por: Tudor, Diana Valentina, et al.
Publicado: (2020)

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
por: Mukherjee, Debabrata, et al.
Publicado: (2003)

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
por: Rawat, Chitra, et al.
Publicado: (2019)

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
por: Laube, Markus, et al.
Publicado: (2013)

Molecular docking analysis of COX-2 for potential inhibitors
por: Selvaraj, Jayaraman, et al.
Publicado: (2020)

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Sethi, Rickinder, et al.
Publicado: (2019)

Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA
por: Saha, Chaitrali, et al.
Publicado: (2015)

New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases
por: Chen, Wujun, et al.
Publicado: (2021)

Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Westwell-Roper, Clara, et al.
Publicado: (2020)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018)

The roles of COX-2 in protozoan infection
por: Wang, Xinlei, et al.
Publicado: (2023)

COX-2 in the neurodegenerative process of Parkinson's disease
por: Teismann, Peter
Publicado: (2012)

In Silico Analysis of the Potential of the Active Compounds Fucoidan and Alginate Derived from Sargassum Sp. as Inhibitors of COX-1 and COX-2
por: Dewi, Lestari
Publicado: (2016)

Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer’s Disease
por: Tyagi, Arti, et al.
Publicado: (2020)

Potential use of COX-2–aromatase inhibitor combinations in breast cancer
por: Bundred, N J, et al.
Publicado: (2005)

Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
por: Mohsin, Noor ul Amin, et al.
Publicado: (2022)

COX inhibitors and breast cancer
por: Mazhar, D, et al.
Publicado: (2006)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
por: Pannunzio, Alessandra, et al.
Publicado: (2018)

Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors
por: Moussa, Nathalie, et al.
Publicado: (2021)

Anaphylaxis to selective COX-2 inhibitors: an unexpected culprit
por: Dias de Castro, Eunice, et al.
Publicado: (2015)

Seizure following the Use of the COX-2 Inhibitor Etoricoxib
por: Arnao, Valentina, et al.
Publicado: (2017)

Cox-2 inhibitors in mandibular third molar surgery
por: Janarthanan, K., et al.
Publicado: (2019)

Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
por: Lees, Peter, et al.
Publicado: (2022)

The mitochondrial TMEM177 associates with COX20 during COX2 biogenesis
por: Lorenzi, Isotta, et al.
Publicado: (2018)

COX-2-PGE(2)-EPs in gynecological cancers
por: Ye, Yao, et al.
Publicado: (2020)

Binding Energy Calculation of Patchouli Alcohol Isomer Cyclooxygenase Complexes Suggested as COX-1/COX-2 Selective Inhibitor
por: Raharjo, Sentot Joko, et al.
Publicado: (2014)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
por: Borer, Jeffrey S, et al.
Publicado: (2005)

Chondroprotective Actions of Selective COX-2 Inhibitors In Vivo: A Systematic Review
por: Timur, Ufuk Tan, et al.
Publicado: (2020)

Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
por: El-Malah, Afaf A., et al.
Publicado: (2022)

Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches
por: Araújo, Pedro H. F., et al.
Publicado: (2020)

COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients
por: Hochberg, Marc C
Publicado: (2003)

Design, synthesis and biological evaluation of new 2-aminothiazole scaffolds as phosphodiesterase type 5 regulators and COX-1/COX-2 inhibitors
por: Hussein, Abdel Haleem M., et al.
Publicado: (2020)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k6arc0qb44s1u8hiibusedplk7